Blue Goat CyberSMMedical Device Cybersecurity
    K
    Podcast · Episode 64

    Traceability Requirements and Documentation Audit Trails with Dr. Basant Bajpai, CEO of Compliance MedQRA

    With Dr. Basant Bajpai - Quality management system implementation delays create cascading failures across medical device development timelines.

    Christian Espinosa, Founder & CEO at Blue Goat Cyber

    By Christian Espinosa, MBA, CISSP

    Founder & CEO · Blue Goat Cyber

    Last reviewed: May 1, 2026

    Listen now

    Episode breakdown

    Key takeaways

    • Delays in implementing a quality management system (QMS) create cascading failures across medical device development timelines, particularly when startups rely on inadequate documentation tools.
    • Starting design controls at the concept stage, rather than later, prevents costly reverse documentation efforts that can delay submissions by 6-12 months.
    • SharePoint and Google Drive are insufficient for medical device documentation due to lack of traceability, version control, and systematic process evidence required during audits.
    • Simple, automated systems enforcing traceability are more effective than manual methods or overly complex enterprise platforms for early-stage medical device companies.
    • Failing to establish a scalable QMS infrastructure early on leads to significant challenges and wholesale system transitions as a company grows.
    • Cybersecurity and quality management are interconnected, and neglecting early cybersecurity planning can delay FDA submissions.
    • The FDA is increasingly focused on robust cybersecurity documentation, necessitating proactive planning and integration with QMS practices.

    Quality management system implementation delays create cascading failures across medical device development timelines. Startups using SharePoint or Google Drive for documentation discover at audit time that these tools provide no traceability, no version control, and no evidence of systematic processes.

    Dr. Basant Bajpai discusses why design controls begin at the concept stage, regardless of whether companies acknowledge them, how reverse documentation costs 6-12 months when manufacturers reach the submission stage without proper systems, and what happens when scaling exposes foundational quality gaps.

    Simple automated systems that enforce traceability outperform both manual approaches and enterprise platforms that startups cannot fully utilize. Starting early with scalable infrastructure prevents wholesale system transitions during growth.

    Practical for medical device startups and innovators.

    Frequently asked questions

    Bring this work to your device

    Need help with fda premarket cybersecurity?

    Blue Goat Cyber delivers fda premarket cybersecurity services for medical device manufacturers - from threat modeling to FDA-ready reports.

    FDA Premarket Cybersecurity Services

    More on FDA Premarket Cybersecurity

    Ready when you are

    Get FDA cleared without the cybersecurity headaches.

    30-minute strategy session. No cost, no commitment - just answers from people who've shipped 250+ submissions.